268
F.- Ye et al. / Phytochemistry Letters 17 (2016) 263–269
(GE Healthcare Bio-Sciences AB, Sweden) was used and column
chromatography (CC) was performed on silica gel (200–300 mesh,
Yantai, China). GC data were recorded on an Agilent N6890
instrument. A preparative column (Shimadzu PRC-ODS EV0233,
yield 2 (7.0 mg, MeOH/H2O 60/40), 4 (20.0 mg, MeOH/H2O 40/60),
5 (30.0 mg, MeOH/H2O 40/60), and 6 (6.0 mg, MeOH/H2O 60/40).
Compounds 3 (6.0 mg, MeOH/H2O 35/65), 16 (20.0 mg, MeOH/H2O
40/60), and 17 (8.0 mg, MeOH/H2O 50/50) were obtained from Fr.7
C
18, 5
m
m, 250 ꢂ 21.2 mm, 500
mL/inj.) was used for preparative
by preparative HPLC. Fr.8 was subjected to preparative HPLC (C18
,
HPLC (Shimadzu LC-20A).
5
m
m, 250 ꢂ 21.2 mm, 500
m
L/inj, flow rate 8.0 mL/min) to yield 18
(4.0 mg, MeOH/H2O 30/70), 19 (8.0 mg, MeOH/H2O 35/65) and 21
3.2. Plant material
(6.0 mg, MeOH/H2O 45/55).
The branches and leaves of I. wardii were collected in Nujiang
County of Yunnan Province, PR China in August 2011 and were
subsequently authenticated by Prof. Zhou Yuan-chuan, the director
of Nujiang Nationality Medicine Plants Institution. An authentic
specimen (No.201108GSBJ) was deposited at the School of
Pharmacy, Shanghai Jiao Tong University.
3.4. Acid hydrolysis of compounds 3, 4, 6
Each compound (5.0 mg) was refluxed in 2 M HCl/MeOH (v/v 1/
1, 2 mL) at 60 ꢁC for 3 h, and the solution was evaporated under N2.
The residue was dissolved in pyridine (100
mL), 1 M L-cysteine
methyl ester hydrochloride (100 L) was added, and the mixture
m
was heated to 60 ꢁC for 2 h. After the reaction mixture was dried in
vacuo, the trimethylsilylation reagent HMDS-TMCS (hexamethyl-
disilazane/Me3SiCl/pyridine 2/1/10) was added, and heating at
60 ꢁC was continued for another 2 h. Finally, the mixture was
partitioned between hexane and H2O (2 mL each), and the hexane
extract was analyzed by gas chromatography (GC) under the
following conditions: column temperature, 255 ꢁC; injection
temperature, 255 ꢁC; flow rate 1.0 mL/min; N2 carrier gas. In the
acid hydrolysate of 4, identification of D-arabinofuranose and D-
xylopyranose was carried out by comparison of the retention time
with those of authentic samples prepared in a similar way. tR:
6.8 min (D-arabinofuranose), 9.7 min (D-xylopyranose) (Li et al.,
1984; Wang et al., 2014).
3.3. Extraction and isolation
The dried branches and leaves of I. wardii (17.4 kg) were
pulverized and extracted with 95% EtOH under reflux for 3ꢂ2 h.
The combined EtOH extracts were concentrated in vacuo to yield
the crude material (1.6 kg), which was successfully portioned with
petroleum ether (5 L ꢂ 4), methylene chloride (5 L ꢂ 4), and ethyl
acetate (5 L ꢂ 4). The CH2Cl2 fraction (100.0 g) was subjected to CC
on silica gel (1200 g, 100–200 mesh, 100 mm ꢂ 60 cm) with a
CH2Cl2/MeOH (100/1–2/1, v/v) gradient eluent to obtain fourteen
subfractions (Fr.1–Fr.14). Compound 8 (10.0 mg) was obtained from
Fr.1 (10.0 g) after CC on silica gel (140 g, 200–300 mesh, 60 mm
ꢂ 60 cm, CH2Cl2/MeOH 20/1) and recrystallized in methanol. Fr.4
(6.0 g) was purified over Sephadex LH-20 (5.0 ꢂ150 cm, MeOH,
3.5. Structural elucidation of new products
1 mL/min) followed by preparative HPLC (C18
,
5
m
m,
250 ꢂ 21.2 mm, 500 L/inj, flow rate 8.0 mL/min) to yield
m
7
Illiciumlignan A (1): Yellowish oil, C30H34O9, ESI–MS m/z: 561
[M+Na]+, HR-ESI–MS: m/z 561.2109 ([M+Na]+, calcd. 561.2095); UV
(MeOH) lmax (log e):217 (2.05), 281 (0.54) nm, [a]20D +3.0 (c 0.1,
MeOH); CD [MeOH c 0.005, De (nm)], ꢀ1.85 (201), +1.19 (209),
+2.18 (220), +5.19 (245), +1.52 (292); IR (KBr) ymax 3434, 2924,1619,
1499,1463,1383,1275,1211,1141,1032, 813 cmꢀ1; 1H NMR (CD3OD,
500 MHz) and 13C NMR data (CD3OD, 125 MHz) (Table 1).
(25.0 mg, MeOH/H2O 45/55), 1 (16.0 mg, MeOH/H2O 45/55), 9
(20.0 mg, MeOH/H2O 45/55), 10 (50.0 mg, MeOH/H2O 45/55), 11
(12.0 mg, MeOH/H2O 75/25), and 12 (12.0 mg, MeOH/H2O 85/15).
Fr.5 (4.0 g) was purified using MCI CC (3.0 ꢂ 60 cm, MeOH/H2O 90/
10) followed by preparative HPLC to yield 13 (30.0 mg, MeOH/H2O
40/60),14 (15.0 mg, MeOH/H2O 40/60),15 (45.0 mg, MeOH/H2O 70/
30) and 20 (20.0 mg, MeOH/H2O 85/15). The EtOAc fraction (100 g)
was subjected to CC on silica gel (1200 g, 100–200 mesh, 100 mm
ꢂ 60 cm) with a CH2Cl2/MeOH (100/1–2/1, v/v) gradient eluent to
obtain ten subfractions (Fr.1ꢀ Fr.10). Fr.6 (5.0 g), Fr.7 (3.0 g) and Fr.8
(4.0 g) were purified over MCI CC (3.0 ꢂ 60 cm, MeOH/H2O 90/10)
followed by Sephadex LH-20 (5.0 ꢂ150 cm, MeOH, 1 mL/min).
Illiciumlignan B (2): Yellowish solid, C32H38O11, m.p. 105.4–
106.2 ꢁC, ESI–MS: m/z 621 [M+Na]+, HR-ESI–MS: m/z 621.2313 ([M
+Na]+, calcd. 621.2306); UV (MeOH) lmax (log
e): 214 (1.95), 230
(1.51), 282 (0.55) nm, [
a
]20 D ꢀ11.2 (c 0.13, MeOH); CD [MeOH c
0.005, De (nm)]: +3.76 (202), +2.55 (212), +1.34 (240), 0.63 (292);
IR (KBr) ymax 3432, 2932, 1733, 1607, 1514, 1456, 1429, 1367, 1266,
1213, 1141, 1032 cmꢀ1 1H NMR (CD3OD, 500 MHz) and 13C NMR
;
Then, the Fr.6 was subjected to preparative HPLC (C18, 5
m
m,
250 ꢂ 21.2 mm, 500 L/inj, flow rate 8.0 mL/min, MeOHꢀꢀH2O) to
m
data (CD3OD, 125 MHz) (Table 2).
Illiciumlignan C (3): Yellowish solid, C25H32O10, m.p. 95.7–
96.6 ꢁC, ESI–MS m/z: 515 [M+Na]+, HR-ESI–MS: m/z 537.1985 ([M
+COOH]+, calcd. 537.1978); UV (MeOH) lmax (log
e
): 213 (1.74), 230
Table 4
(1.72), 284 (0.43) nm, [
a
]20D ꢀ3.33 (c 0.21, MeOH); CD [MeOH c
IC50 values of compounds 1–21 against four human tumor cell lines.
0.005, De (nm)]: +5.52 (212), ꢀ4.55 (242), ꢀ2.55 (292); IR (KBr)
ymax 3415, 2924, 1607,1517, 1499, 1452, 1430, 1384, 1215, 1211,
1040 cmꢀ1; 1H NMR (CD3OD, 500 MHz) and 13C NMR data (CD3OD,
125 MHz) (Table 3).
Compounds
IC50
(mM)
A549
HCT116
SKOV3
HepG2
1
2
3
4
5
6
7
8
>100.00
>100.00
>100.00
>100.00
>100.00
>100.00
>100.00
14.88
>100.00
>100.00
>100.00
>100.00
>100.00
>100.00
>100.00
2.78
>100.00
>100.00
>100.00
8.67
>100.00
>100.00
>100.00
>100.00
>100.00
>100.00
>100.00
5.65
Illiciumlignan D (4): Yellowish solid, C25H32O10, m.p. 84.4–
85.3 ꢁC, ESI–MS m/z: 515 [M+Na]+, HR-ESI–MS: m/z 515.1888 ([M
+Na]+, calcd. 515.1888); UV (MeOH) lmax (log
e): 214 (1.98), 232
10.66
>100.00
>100.00
6.08
(1.58), 283 (0.61) nm; [
a
]20D ꢀ26.4 (c 0.22, MeOH); CD [MeOH c
0.005, De (nm)]: ꢀ3.19 (202), ꢀ1.24 (223), +4.41 (240), +2.03 (290);
IR (KBr) ymax 3419, 2936, 1607, 1518, 1498, 1455, 1275, 1211, 1141,
1034 cmꢀ1; 1H NMR(CD3OD, 500 MHz) and 13C NMR data (CD3OD,
125 MHz) (Table 3).
10
12
18
20
DOX
>100.00
26.04
>100.00
28.22
80.47
20.48
>100.00
2.70
9.36
36.25
11.47
13.31
3.09
>100.00
14.61
>100.00
11.31
Illiciumlignan E (5): Yellowish solid, C30H36O10, m.p. 90.2–
0.72
0.16
0.10
91.0 ꢁC, ESI–MS: m/z 579 [M+Na]+, HR-ESI–MS: m/z 579.2214 ([M
+Na]+, calcd. 579.2201); UV (MeOH) lmax (log
e): 214 (2.01), 230
Doxorubicin (DOX) was used as a positive control.